Opinion on the new advanced lipid-lowering therapy

Abstract

The paper focuses on monoclonal antibody (Monoclonal Antibodies - MAB) against enzyme PCSK9 (they are termed inhibitors (PCSK9-i).

Keywords

• Hypercholesterolemia
• hypolipidemics
• LDL-cholesterol
• statins
• cardiovascular disease